Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients: Searching for the Optimal Dose. A Prospective, Randomized Trial

NCT01912716 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT01912716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01912716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients: Searching for the Optimal Dose. A Prospective, Randomized Trial
Lead sponsor
Indiana University
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2013
Completion date
October 31, 2018
Enrollment
1,037 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp pancreatitis